Browse > Article
http://dx.doi.org/10.5352/JLS.2021.31.3.346

The Preventive Effect of Bacillus polyfermenticus KJS-2 and Bacillus mojavensis KJS-3 on Triton WR-1339-induced Hyperlipidemia  

Lee, Jin Young (Department of Pharmacy, Kyungsung University)
Lee, Seung Jae (Department of Pharmacy, Kyungsung University)
Kim, Hyung Hoi (Biomedical Research Institute, Busan National University Hospital)
Kang, Jae Seon (Department of Pharmacy, Kyungsung University)
Publication Information
Journal of Life Science / v.31, no.3, 2021 , pp. 346-355 More about this Journal
Abstract
The purpose of this study was to evaluate the possibility that administration of Bacillus polyfermenticus KJS-2 (BP2), Bacillus mojavensis KJS-3 (Moja3), and their mixtures could control serum lipid levels. We observed changes in the blood cell level, metabolic function evaluation, and blood lipid levels after two weeks of oral administration of these microbial strains to hyperlipidemia-induced rats. Measurements of major cell changes in the white blood cells (WBC) indicated no significant effects due to the administration of the microbial strains. Platelet (PLT) levels decreased by 18.4% in the Triton WR-1339-treated group (NCON) and recovered to the control (CON) group levels in the positive control (PCON) group and the microbial strain-administered groups (p<0.05). No functional changes were observed in red blood cells (RBC) by Triton WR-1339-induced hyperlipidemia. The blood AST, ALT, BUN, and creatinine levels did not indicated effects on liver and kidney function, and all rats administered the microbial mixture recovered. The blood lipid levels in the microbe-treated groups indicated reduced levels of triglyceride (TG) and total cholesterol (TC), and increased levels of serum HDL cholesterol. The HMG-CoA inhibition rate of 7-O-succinyl macrolactin A (SMA) produced by BP2 showed similar activity at a concentration of 1,000 times lower than that achieved with atorvastatin. The administration of the microbial strains to the Triton WR-1339-induced rat model of hyperlipidemia resulted in reduced weight gain without affecting the food and water intake. Thus, blood circulation can be improved by controlling serum lipid levels by the combined administration of the BP2 and Moja3 microbial strains.
Keywords
Bacillus mojavensis KJS-3; Bacillus polyfermenticus KJS-2; HMG-CoA reductase; hyperlipidemia; lipid metabolism;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Akrami, R., Gharaei, A., Mansour, M. R. and Galeshi, A. 2015. Effects of dietary onion (Allium cepa) powder on growth, innate immune response and hemato-biochemical parameters of beluga (Huso huso Linnaeus, 1754) juvenile. Fish Shellfish Immunol. 45, 828-834.   DOI
2 Cho, M. S. 2010. Production optimization of spore and macrolatin A from Bacillus polyfermenticus KJS-2. Master. dissertation, Inje university, Kimhae, Korea.
3 Choi, S. M., Park, M. H., Jung, T. S., Moon, K. H., Kim, K. M. and Kang, J. S. 2011. Characterization of Bacillus mojavensis KJS-3 for industrial applications. Arch. Pharm. Res. 34, 289-298.   DOI
4 El-Demerdash, F. M., Yousef, M. I. and El-Naga, N. I. 2005. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 43, 57-63.   DOI
5 Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569-1582.   DOI
6 Grundy, S. M. 1998. Statin trials and goals of cholesterol-lowering therapy. Circulation 97, 1436-1439.   DOI
7 Kim, D. H., Kang, K. R., Kim, H. W., Yoon, S. Y., Kim, C. G., Yamaguchi, T., Kyung, S. J. and Kang, J. S. 2010. Structure determination of macrolactin compounds with antibacterial activities isolated from Bacillus polyfermenticus KJS2. J. Life Sci. 20, 1792-1800.   DOI
8 Huang, X., Wu, X., Yan, S. and Lan, T. 2018. Lipid-lowering effect of propolis in mice with triton-WR1339-induced hyperlipidemia and its mechanism for regulating lipid metabolism. Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 38, 1020-1024.
9 Jun, K. D., Kim, H. J., Lee, K. H., Paik, H. D. and Kang, J. S. 2002. Characterization of Bacillus polyfermenticus SCD as a probiotic. Kor. J. Microbiol. Biotechnol. 30, 359-366.
10 Kawamoto, S., Kawamura, T., Miyazaki, Y. and Hosoya, T. 2007. Effects of atorvastatin on hyperlipidemia in kidney disease patients. Nihon Jinzo Gakkai Shi. 49, 41-48.
11 Kim, D. H., Kim, H. K., Kim, K. M., Kim, C. K., Jeong, M. H., Ko, C. Y., Moon, K. H. and Kang, J. S. 2011. Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Arch. Pharm. Res. 34, 147-152.   DOI
12 Kim, K. M., Kim, B. S. and Kang, J. S. 2018. The preventive effect of Bacillus polyfermenticus KJS-2 and Angelica gigas Nakai extract on Triton WR-1339-induced hyperlipidemia. J. Life Sci. 28, 726-732.   DOI
13 Sonmez, O. and Sonmez, M. 2017. Role of platelets in immune system and inflammation. Proto. Biomed. J. 2, 311-314.   DOI
14 Kim, K. M., Kim, D. H., Park, Y. S. and Kang, J. S. 2009. Characterization of Bacillus polyfermenticus KJS-2 as a Probiotic. J. Microbiol. Biotechnol. 19, 1013-1018.   DOI
15 Kwon, R. H. and Ha, B. J. 2014. Protection of Saururus Chinensis extract against liver oxidative stress in rats of Triton WR-1339-induced hyperlipidemia. Toxicol. Res. 30, 291-296.   DOI
16 Lennernas, H. 2003. Clinical pharmacokinetics of atorvastatin. Clin. Pharmacokinet. 42, 1141-1160.   DOI
17 Park, Y. H., Lee, J. S. and Lee, Y. J. 1993. Distribution of serum lipid by age and the relation of serum lipid to degree of obesity and blood pressure in Korean adults. Kor. J. Lipidiology 3, 165-180.
18 Pearlman, B. L. 2002. The new cholesterol guidelines. Applying them in clinical practice. Postgrad. Med. 112, 13-48.   DOI
19 Takahashi, A., Sekiya, C., Yazaki, Y., Ono, M., Sato, H., Hasebe, C., Ishikawa, Y., Okuno, K., Yamada, M. and Namiki, M. 1986. Hepatic GOT and GPT activities in patients with various liver diseases-especially alcoholic liver disease. Hokkaido Igaku Zasshi 61, 431-436.
20 Vetsika, E. K., Koukos, A. and Kotsakis, A. 2019. MyeloidDerived suppressor cells: major figures that shape the immunosuppressive and angiogenic network in cancer. Cells 8, 1647.   DOI
21 Virginia, A., Rachmawati, H., Riani, C. and Retnoningrum, D. S. 2016. Study of HMG-CoA reductase inhibition activity of the hydrolyzed product of snakehead fish (Channa striata) skin collagen with 50 kDa collagenase from Bacillus licheniformis F11.4. Sci. Pharm. 84, 81-88.   DOI
22 Wierzbicki, A. S. 2003. New lipid-lowering agents. Expert Opin. Emerg. Drugs 8, 365-376.   DOI
23 Nguyen, P., Leray, V., Diez, M., Serisier, S., Le Bloc'h, J., Siliart, B. and Dumon, H. 2008. Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. 92, 272-283.   DOI
24 Zarzecki, M. S., Araujo, S. M., Bortolotto, V. C., Paula, M. T., Jesse, C. R. and Prigol, M. 2014. Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice. Toxicol. Rep. 12, 200-208.